gvtcx

NHS National Generic Pharmaceuticals - Imatinib and Valganciclovir

NHS England Published 16 Nov 2018 Contracts Finder

key details

Value£2,763,678
Statuscomplete
Category (CPV) 33600000 +1 more
RegionNorth East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West
Deadline14 Dec 2018
Contract start11 May 2019
Contract end31 Jan 2020
Procedureopen
SME suitableYes
OCIDocds-b5fd17-d85eec12-565d-4ab0-b242-cb6373e2baff

Award

SupplierValueDateStatus
Please see list of awarded suppliers (Including SME status) at t £2,763,678 18 Feb 2019 active

description

Invitation to offer for NHS National Generic Pharmaceuticals - Imatinib and Valganciclovir

Offer reference number: CM/PHG/18/5573

Period of framework agreement: The total maximum duration of the framework agreement to be no more than 17 months

Potential periods of call-offs under the framework agreement:

All products and all regions: 11 May 2019 to 31 January 2020 (8.5 months)

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
17 Apr 2019 Award (award) · 4271d1f0-9be4-4320-ac72-936fec74c406-284455

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.